Immunoglobulin, subcutaneous infusion solution for extravascular use 100mg/1ml

This tender concerns the procurement of immunoglobulin, specifically a subcutaneous infusion solution for extravascular use, with a concentration of 100mg/1ml. The subject of the procurement is a pharmaceutical product intended for therapeutic administration. While the description is brief, it clearly identifies the specific medical product required. Further details regarding the quantity, packaging, delivery schedule, and specific quality standards or pharmacopoeial requirements would typically be found in the full tender documentation. This type of procurement is crucial for healthcare providers to ensure the availability of essential medications for patient treatment. The tender likely aims to secure a reliable supply of this immunoglobulin product, potentially through a framework agreement or a direct contract with a qualified supplier. Interested parties are expected to be manufacturers or authorized distributors capable of meeting the stringent regulatory and quality requirements associated with pharmaceutical products. The focus on subcutaneous infusion indicates a specific mode of administration, suggesting the product is formulated for ease of use in clinical or homecare settings. The concentration of 100mg/1ml is a critical parameter defining the product's potency and dosage. This procurement is vital for maintaining patient care pathways that rely on immunoglobulin therapy.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Estonia, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.